Bumper Offer - Urjas oil Just @ Rs. 1
Lozivate Lotion 30ml, a prescription drug, is manufactured in various forms such as Lotion. Psoriasis, Eczema, Dermatitis are some of its major therapeutic uses. Other than this, Lozivate Lotion 30ml has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Lozivate Lotion 30ml depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Lozivate Lotion 30ml as well, which are listed below. Such side effects of Lozivate Lotion 30ml normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Lozivate Lotion 30ml's effect is Moderate during pregnancy and Mild for lactating mothers. Further, the section on Lozivate Lotion 30ml related warnings talks about Lozivate Lotion 30ml's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Lozivate Lotion 30ml contraindications section.
Besides this, Lozivate Lotion 30ml may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Lozivate Lotion 30ml, it is important to know that it is safe while driving, and is habit-forming.
Lozivate Lotion 30ml is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Lozivate Lotion 30ml is used -
Moderate
Mild
Is the use of Lozivate Lotion 30ml safe for pregnant women?
Pregnant women may experience moderate side effects from Lozivate. It is best to stop taking Lozivate immediately and inform your doctor if you notice any discomfort.
Is the use of Lozivate Lotion 30ml safe during breastfeeding?
Side effects of Lozivate on breastfeeding women are very mild.
What is the effect of Lozivate Lotion 30ml on the Kidneys?
Lozivate is not harmful for kidneys.
What is the effect of Lozivate Lotion 30ml on the Liver?
Using Lozivate does not have any harmful effects on the liver.
What is the effect of Lozivate Lotion 30ml on the Heart?
Lozivate is not harmful for the heart.
Lozivate Lotion 30ml should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lozivate Lotion 30ml unless your doctor advises you to do so -
Is this Lozivate Lotion 30ml habit forming or addictive?
Lozivate Lotion 30ml is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Lozivate Lotion 30ml since it does not cause drowsiness.
Is it safe?
Lozivate Lotion 30ml should be used only after doctor's advice.
Is it able to treat mental disorders?
Lozivate Lotion 30ml is unable to treat or cure mental disorders.
Interaction between Food and Lozivate Lotion 30ml
Due to a lack of research, nothing can be said about the consequences of taking Lozivate Lotion 30ml together with food.
Interaction between Alcohol and Lozivate Lotion 30ml
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Lozivate Lotion 30ml.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 889
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 889
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 889
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 889
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370